G D Kennovin
Overview
Explore the profile of G D Kennovin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
55
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Burns D, Ruddock M, Walker M, Allen J, Kennovin G, Hirst D
Eur J Pharmacol
. 1999 Jul;
374(2):213-20.
PMID: 10422762
Previously, we have shown that nicotinamide inhibits both high [K+]- and phenylephrine-induced constrictions in a dose-dependent manner in rat tail arteries. We have now investigated the effect of nicotinamide on...
2.
Genever P, Maxfield S, Kennovin G, Maltman J, Bowgen C, Raxworthy M, et al.
J Invest Dermatol
. 1999 Mar;
112(3):337-42.
PMID: 10084312
Phenotypic alterations in keratinocyte behavior are essential for maintaining epidermal integrity during growth and wound repair and rely on co-ordinated cell signaling events. Numerous growth factors and cytokines have been...
3.
Burns D, Ruddock M, Brown J, Kennovin G, Dykes E, Flitney F, et al.
Biochem Soc Trans
. 1997 Feb;
25(1):132S.
PMID: 9057030
No abstract available.
4.
Flitney F, Megson I, Thomson J, Kennovin G, Butler A
Br J Pharmacol
. 1996 Apr;
117(7):1549-57.
PMID: 8730753
1. The vasodilator properties and photochemical decomposition of two synthetic iron-sulphur-nitrosyl clusters (cluster A: [Fe4S4(NO)4], tetranitrosyl-tetra-mu 3-sulphido-tetrahedro-tetrairon; and B:[Fe4S3 (NO)7]-1, heptanitrosyl-tri-mu 3-thioxotetraferrate(-1)) have been investigated. Experiments were carried out on...
5.
Hirst D, Kennovin G, Tozer G, Prise V, Flitney E
Acta Oncol
. 1995 Jan;
34(3):397-400.
PMID: 7779429
We have studied the ability of the radiosensitizer nicotinamide (NA) to alter the contractility of normal and tumour blood vessels using an ex vivo isolated artery perfusion system. NA at...
6.
Hirst D, Kennovin G, Flitney F
Br J Radiol
. 1994 Aug;
67(800):795-9.
PMID: 8087486
Nicotinamide (NA) is currently entering clinical trials as a radiosensitizer. A major component of its activity is the improvement of tumour oxygenation resulting from a reduction in microregional ischaemia. NA...
7.
Kennovin G, Flitney F, Hirst D
Adv Exp Med Biol
. 1994 Jan;
345:411-6.
PMID: 7521565
No abstract available.